Overview

131I-Labeled MIBG for Refractory Neuroblastoma: A Compassionate Use Protocol

Status:
Available
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This is a compassionate use protocol to allow patients with advanced neuroblastoma palliative access to 131I-metaiodobenzylguanidine (131I-MIBG).
Details
Lead Sponsor:
Kieuhoa Vo
University of California, San Francisco
Collaborator:
Cannonball Kids Cancer Foundation, Inc
Treatments:
3-Iodobenzylguanidine